Similar articles

• Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.

  Fennema D, Phillips IR, Shephard EA. Fennema D, et al. Drug Metab Dispos. 2016 Nov;44(11):1839-1850. doi: 10.1124/dmd.116.070615. Epub 2016 May 17. Drug Metab Dispos. 2016. PMID: 27190056 Free PMC article. Review.
• Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.

  Iglesias-Carres L, Chadwick-Corbin SA, Sweet MG, Neilson AP. Iglesias-Carres L, et al. J Nutr Biochem. 2023 Oct;120:109428. doi: 10.1016/j.jnutbio.2023.109428. Epub 2023 Aug 5. J Nutr Biochem. 2023. PMID: 37549832
• Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.

  Zhu W, Buffa JA, Wang Z, Warrier M, Schugar R, Shih DM, Gupta N, Gregory JC, Org E, Fu X, Li L, DiDonato JA, Lusis AJ, Brown JM, Hazen SL. Zhu W, et al. J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9. J Thromb Haemost. 2018. PMID: 29981269 Free PMC article.
• [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].

  Shimizu M. Shimizu M. Yakugaku Zasshi. 2009 Nov;129(11):1351-6. doi: 10.1248/yakushi.129.1351. Yakugaku Zasshi. 2009. PMID: 19881207 Review. Japanese.
• Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation.

  Kim SJ, Bale S, Verma P, Wan Q, Ma F, Gudjonsson JE, Hazen SL, Harms PW, Tsou PS, Khanna D, Tsoi LC, Gupta N, Ho KJ, Varga J. Kim SJ, et al. iScience. 2022 Jun 26;25(7):104669. doi: 10.1016/j.isci.2022.104669. eCollection 2022 Jul 15. iScience. 2022. PMID: 35856022 Free PMC article.